Insulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in Type 1 diabetes mellitus

被引:4
|
作者
Bruttomesso, D [1 ]
Iori, E [1 ]
Kiwanuka, E [1 ]
Zanetti, M [1 ]
Pianta, A [1 ]
Vettore, M [1 ]
Tiengo, A [1 ]
Tessari, P [1 ]
机构
[1] Univ Padua, Chair Metab, Dept Clin & Expt Med, Padua, Italy
关键词
fractional synthetic rates; protein synthesis; precursor product; amino acid tracers;
D O I
10.1046/j.1464-5491.2001.00606.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The effect of metabolic control on hepatic synthesis of plasma proteins in Type 1 diabetes mellitus (T1DM), in the post-absorptive and post-prandial state, is not known. Methods We measured fractional synthetic rates (FSR) of albumin and fibrinogen in six insulin-infused T1DM patients and in five to nine control subjects, before and for approx. 4 h after a mixed liquid meal. Phenylalanine tracer precursor/product relationships and steady-state conditions were used. In the post-absorptive state, patients were studied in near euglycaemic conditions after an overnight intravenous insulin infusion. During the meal (approx. 11 kcal/kg), the insulin infusion rate was increased to maintain plasma glucose concentrations below approx. 10 mmol/l. Results Post-absorptive FSR of albumin (5.7 +/- 0.6%/day) and fibrinogen (11.3 +/- 0.6%/day) in T1DM were similar to control values (6.4 +/- 0.9 and 13.1 +/- 1.1, respectively). After the meal, albumin FSR increased (P = 0.0032 by ANOVA) in both groups (T1DM, to 14.4 +/- 2.7%/day; controls, to 18.2 +/- 3.7%/day). Fibrinogen FSR also increased (P = 0.0048 by ANOVA) in both the T1DM (to 18.2 +/- 2.6) and the control subjects (to 27.3 +/- 6.2). There was no difference between T1DM and control subjects in the postprandial FSR of both proteins. Conclusions Albumin and fibrinogen FSR in T1DM can be maintained within near-normal ranges by insulin infusion under post-absorptive and postprandial conditions.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 50 条
  • [41] METABOLISM OF ALBUMIN AND FIBRINOGEN IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    BENTHANSEN, L
    DECKERT, T
    [J]. DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1988, 7 (04): : 159 - 164
  • [42] Post-prandial administration of insulin lispro with a high fat meal minimizes risk of hypoglycaemia in Type 1 diabetes
    McAulay, V
    Ferguson, SC
    Frier, BM
    [J]. DIABETIC MEDICINE, 2004, 21 (08) : 953 - 954
  • [43] Nutritional load in post-prandial oxidative stress and the pathogeneses of diabetes mellitus
    He, Fangzhou
    Liu, Junshi
    Huang, Yuanding
    Chen, Lan
    Rizi, Ehsan Parvaresh
    Ke, Zhang
    Ke, Lijing
    Loh, Tze Ping
    Niu, Meng
    Peng, Weng Kung
    [J]. NPJ SCIENCE OF FOOD, 2024, 8 (01)
  • [44] Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients
    van Wijk, Jeroen
    Coll, Blai
    Cabezas, Manuel Castro
    Koning, Eelco
    Camps, Jordi
    Rabelink, Ton
    Mackness, Bharti
    Joven, Jorge
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (12) : 1134 - 1137
  • [45] The effect of insulin aspart on post-prandial metabolism and lipid profile in Type 2 diabetes.
    Gallagher, A
    Home, PD
    [J]. DIABETOLOGIA, 2002, 45 : A253 - A254
  • [46] Subcutaneous exendin-4 lowers both post-prandial and fasting plasma glucose in Type 2 diabetes
    Maksoud, H
    Dudley, C
    Manley, SE
    Levy, JC
    [J]. DIABETOLOGIA, 2000, 43 : A144 - A144
  • [47] Post-prandial glucose excursions following three methods of bolus insulin administration in adolescent girls with type 1 diabetes
    Kernell, A.
    Lindholm-Olinder, A.
    Runefors, J.
    [J]. DIABETOLOGIA, 2006, 49 : 112 - 113
  • [48] Type II Diabetes Mellitus Diagnosed after Workup for an Episode of Prolonged Post-Prandial Hypoglycemia.
    Singer, F.
    Zerez, C. R.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [49] Differential effects of reducing fasting vs post-prandial glucose on symptoms of hyperglycemia and hypoglycemia in type 2 diabetes
    Testa, MA
    Hayes, JF
    Turner, RR
    Simonson, DC
    [J]. DIABETES, 2002, 51 : A478 - A479
  • [50] Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes
    Raskin, P
    Rappaport, EB
    Cole, ST
    Yan, Y
    Patwardhan, R
    Freed, MI
    [J]. DIABETOLOGIA, 2000, 43 (03) : 278 - 284